Page last updated: 2024-09-04

ezetimibe and Cardiac Remodeling, Ventricular

ezetimibe has been researched along with Cardiac Remodeling, Ventricular in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alves, CMR; Berwanger, O; Bianco, HT; Caixeta, A; Carvalho, ACC; Damiani, LP; Fonseca, FAH; Fonseca, HA; França, CN; Izar, MC; Klassen, A; Maugeri, IML; Moreira, FT; Pinto, IM; Soriano Lopes, A; Szarf, G; Tavares, MFM	1
Chang, Y; Chen, YG; Ji, XP; Li, CB; Li, XX; Liu, BS; Xu, F; Zhang, C; Zhao, L	1

Trials

1 trial(s) available for ezetimibe and Cardiac Remodeling, Ventricular

Article	Year
Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute My Trials, 2017, Dec-19, Volume: 18, Issue:1 Topics: Adenosine; Anti-Inflammatory Agents; B-Lymphocytes; Biomarkers; Brazil; Clinical Protocols; Clopidogrel; Coronary Angiography; Drug Therapy, Combination; Enzyme-Linked Immunospot Assay; Ezetimibe; Female; Flow Cytometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Magnetic Resonance Imaging; Male; Metabolomics; Platelet Aggregation Inhibitors; Proteomics; Research Design; Rosuvastatin Calcium; Simvastatin; ST Elevation Myocardial Infarction; Stroke Volume; T-Lymphocytes; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling	2017

Article

Year

Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute My

Trials, 2017, Dec-19, Volume: 18, Issue:1

Topics: Adenosine; Anti-Inflammatory Agents; B-Lymphocytes; Biomarkers; Brazil; Clinical Protocols; Clopidogrel; Coronary Angiography; Drug Therapy, Combination; Enzyme-Linked Immunospot Assay; Ezetimibe; Female; Flow Cytometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Magnetic Resonance Imaging; Male; Metabolomics; Platelet Aggregation Inhibitors; Proteomics; Research Design; Rosuvastatin Calcium; Simvastatin; ST Elevation Myocardial Infarction; Stroke Volume; T-Lymphocytes; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling

2017

Other Studies

1 other study(ies) available for ezetimibe and Cardiac Remodeling, Ventricular

Article	Year
Ezetimibe prevents myocardial remodeling in an obese rat model by inhibiting inflammation. Acta biochimica Polonica, 2018, Volume: 65, Issue:3 Topics: Animals; Anticholesteremic Agents; Blotting, Western; C-Reactive Protein; Cardiomegaly; Collagen; Diet, High-Fat; Ezetimibe; Heart; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Myocardium; Obesity; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Vascular Cell Adhesion Molecule-1; Ventricular Remodeling	2018

Article

Year

Ezetimibe prevents myocardial remodeling in an obese rat model by inhibiting inflammation.

Acta biochimica Polonica, 2018, Volume: 65, Issue:3

Topics: Animals; Anticholesteremic Agents; Blotting, Western; C-Reactive Protein; Cardiomegaly; Collagen; Diet, High-Fat; Ezetimibe; Heart; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Myocardium; Obesity; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Vascular Cell Adhesion Molecule-1; Ventricular Remodeling

2018